Meprobamate — Class II drug recall D-203-2013
Terminated recall by Watson Laboratories Inc, reported 2013-03-27, distributed nationwide. Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out
| Recall number | D-203-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Watson Laboratories Inc, Corona, CA, United States |
| Recall initiated | 2013-02-08 |
| Classified | 2013-03-19 |
| Reported by FDA | 2013-03-27 |
| Terminated | 2014-01-31 |
| Distributed | Nationwide (US) |
| Quantity | 9,824 bottles |
| Reason classes | specification failure |
| NDC | 09591-5239-01 |
Product
Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 9591-5239-01
Reason for recall
Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-203-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.